The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
New gene editing methods have been introduced in the country, bringing new hope to couples who tested positive for certain ...
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, ...
Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention ...
As if we didn’t have enough to stress about, new research shows that day-to-day tension and worry can increase the risk of ...
Reviewed by Dietitian Maria Laura Haddad-Garcia About 30 percent of the U.S. population has metabolic syndrome, a cluster of ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
Ozempic is well-known for its ability to manage type 2 diabetes and aid weight loss. . But as more research emerges, additional health benefits of the GLP-1 drug are being uncovered. Previous studies ...
These evaluations measure how efficiently the body converts nutrients into energy, assessing mitochondrial function, insulin sensitivity, and metabolic flexibility. Specialised tests like glucose ...
There’s no cure for restless legs syndrome – a distressing disorder that mainly affects sufferers at night – but there are ...